» Articles » PMID: 28433553

Identification and Validation of MicroRNAs Directly Regulating the UDP-glucuronosyltransferase 1A Subfamily Enzymes by a Functional Genomics Approach

Overview
Date 2017 Apr 24
PMID 28433553
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Posttranscriptional repression of UDP-glucuronosyltransferase (UGT) 1A expression by microRNAs (miRNAs) may be an important mechanism underlying interindividual variability in drug glucuronidation. Furthermore, the UGT1A 3'-UTR shared by all UGT1A enzymes is polymorphic, containing three linked SNPs (rs10929303, rs1042640, and rs8330) that could influence miRNA binding. The aim of this study was to identify the complete complement of miRNAs that could regulate UGT1A expression through binding to the reference and/or common variant UGT1A 3'-UTR. Luciferase reporter plasmids containing either the reference or variant UGT1A 3'-UTR were screened against a 2048 human miRNA library to identify those miRNAs that decrease luciferase activity by at least 30% when co-transfected into HEK293 cells. Four novel miRNAs (miR-103b, miR-141-3p, miR-200a-3p, and miR-376b-3p) were identified that repressed both reference and variant UGT1A 3'-UTR, while two other miRNAs selectively repressed the reference (miR-1286) or variant (miR-21-3p) 3'-UTR. Deletion and mutagenesis studies confirmed the binding site location for each miRNA. rs8330 disrupted miR-1286 binding to the reference UGT1A 3'-UTR, while rs10929303 enhanced miR-21-3p binding to the variant 3'-UTR. Transfection of miR-21-3p, miR-103b, miR-141-3p, miR-200a-3p, and miR-376b-3p mimics into LS180 human intestinal cells showed repression of UGT1A1 and UGT1A6 mediated glucuronidation and mRNA without affecting UGT2B7 activity or mRNA. Furthermore, transfection of miR-21-3p, miR-141-3p, and miR-200a-3p into primary human hepatocytes, repressed UGT1A1 activity and mRNA without affecting CYP3A activity. Finally, miR-21-3p and miR-200a-3p expression were negatively correlated with UGT1A6 activity and mRNA in human liver samples. Thus, UGT1A is regulated by multiple miRNAs with some showing allele-dependent effects.

Citing Articles

The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage.

Calin G, Hube F, Ladomery M, Delihas N, Ferracin M, Poliseno L Noncoding RNA. 2024; 10(6.

PMID: 39728607 PMC: 11679529. DOI: 10.3390/ncrna10060062.


Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine.

Jackson K, Achour B, Lee J, Geffert R, Beers J, Latham B Drug Metab Dispos. 2023; 51(10):1238-1253.

PMID: 37419681 PMC: 10506699. DOI: 10.1124/dmd.122.001066.


Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition.

Tu M, Yu A Curr Drug Metab. 2023; 24(3):175-189.

PMID: 37170982 PMC: 10825985. DOI: 10.2174/1389200224666230425232433.


SNPs in 3'UTR miRNA Target Sequences Associated with Individual Drug Susceptibility.

Rykova E, Ershov N, Damarov I, Merkulova T Int J Mol Sci. 2022; 23(22).

PMID: 36430200 PMC: 9692299. DOI: 10.3390/ijms232213725.


MicroRNAs and cancer drug resistance: over two thousand characters in search of a role.

Gomes B, Rueff J, Rodrigues A Cancer Drug Resist. 2022; 2(3):618-633.

PMID: 35582590 PMC: 8992528. DOI: 10.20517/cdr.2019.55.


References
1.
Douglas S, Shenoda B, Qureshi R, Sacan A, Alexander G, Perreault M . Analgesic Response to Intravenous Ketamine Is Linked to a Circulating microRNA Signature in Female Patients With Complex Regional Pain Syndrome. J Pain. 2015; 16(9):814-24. DOI: 10.1016/j.jpain.2015.05.008. View

2.
Betel D, Wilson M, Gabow A, Marks D, Sander C . The microRNA.org resource: targets and expression. Nucleic Acids Res. 2007; 36(Database issue):D149-53. PMC: 2238905. DOI: 10.1093/nar/gkm995. View

3.
Arab-Alameddine M, Fayet-Mello A, Lubomirov R, Neely M, di Iulio J, Owen A . Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals. Antimicrob Agents Chemother. 2012; 56(6):2959-66. PMC: 3370715. DOI: 10.1128/AAC.05424-11. View

4.
Dluzen D, Sun D, Salzberg A, Jones N, Bushey R, Robertson G . Regulation of UDP-glucuronosyltransferase 1A1 expression and activity by microRNA 491-3p. J Pharmacol Exp Ther. 2014; 348(3):465-77. PMC: 3935146. DOI: 10.1124/jpet.113.210658. View

5.
Krishnaswamy S, Duan S, von Moltke L, Greenblatt D, Court M . Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6. Drug Metab Dispos. 2002; 31(1):133-9. DOI: 10.1124/dmd.31.1.133. View